|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C12P 21/08 | (2006.01) |
| (11) | Number of the document | 1781705 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05787743.3 |
| Date of filing the European patent application | 2005-06-20 | |
| (97) | Date of publication of the European application | 2007-05-09 |
| (45) | Date of publication and mention of the grant of the patent | 2014-10-08 |
| (46) | Date of publication of the claims translation | 2015-01-26 |
| (86) | Number | PCT/US2005/021951 |
| Date | 2005-06-20 |
| (87) | Number | WO 2006/002177 |
| Date | 2006-01-05 |
| (30) | Number | Date | Country code |
| 581747 P | 2004-06-21 | US |
| (72) |
CARDARELLI, Josephine M., US
WITTE, Alison, US
SRINIVASAN, Mohan, US
|
| (73) |
E. R. Squibb & Sons, L.L.C.,
Route 206 and Province Line Road, Princeton, NJ 08540,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Interferono alfa receptoriaus-I antikūnai ir jų panaudojimas |
| INTERFERON ALPHA RECEPTOR I ANTIBODIES AND THEIR USES |
| Payment date | Validity (years) | Amount | |
| 2017-05-18 | 13 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-06-20 |